Founded in 2016, Neurofenix is a pioneering company in the Health Care and Autonomous and Sensor Tech sectors, headquartered in the United States. The company is at the forefront of virtual neurorehabilitation, focusing on at-home therapy solutions supported by virtual therapists. Their platform is tailored to enhance recovery for post-stroke and neuro patients, offering seamless integration with existing healthcare pathways.
Recently, Neurofenix secured a £5.90M Series A investment from prominent investors such as Albion VC, HTH VC, and InHealth Ventures on 29 August 2022. This funding underscores investor confidence in their innovative approach and potential for growth in a market driven by the increasing demand for convenient and effective rehabilitation solutions.
The company presents a compelling opportunity for investors looking to capitalize on cutting-edge rehabilitation technology that not only innovates patient care but also has measurable impacts on wellness and recovery.